Session date: 
01/16/2019 - 12:10pm to 1:00pm

Omar F. Abou Ezzeddine,  M.D., C.M., M.S.
Assistant Professor of Cardiology

Angela Dispenzieri,  M.D.
Professor of Laboratory Medicine and Pathology
Professor of Hematology

Martha Grogan,  M.D.
Assistant Professor of Cardiology

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

  • Recognize the increasing awareness of age-related amyloidosis
  • Identify when to consider the diagnosis of age-related amyloidosis
  • Differentiate between age-related amyloidosis and other types of amyloidosis
  • Demonstrate existing and emerging therapies for these treatable diseases

Financial Disclosures:

  • Dr. About Ezzeddine: Grant/Research Support - Pfizer, Inc.
  • Dr. Dispenzieri: Grant/Research Support - Takeda, Pfizer, Prothena, Celgene, Janssen, and Alnylam
  • Dr. Grogran: Grant/Research Support - Pfizer, Inc., Alnylam, Eidos, Prothena

Off Label/Investigational Uses:

  • None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Presenter: 
Omar F. Abou Ezzeddine, M.D., C.M., M.S.
Co-presenter: 
Angela Dispenzieri, M.D.
Additional presenter: 
Martha Grogan, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota